Life Insurance Is Not an Investment

Life insurance is not an investment.

Not as a matter of positioning or preference, but as a matter of what the contract is and which body of law governs it.

And a great deal of the argument about this strategy comes from people, on both sides, who have accepted the wrong framing before they start.

What a policy actually is

A contract with an insurer to pay a death benefit when the insured dies.

Regulated as insurance, under provincial insurance legislation, by provincial regulators. Not as a security, and not by securities regulators.

Sold under an insurance licence. This practice holds one. Investment products require separate registration it does not hold, which is not a technicality: it determines what may lawfully be said and to whom.

It has a contractual value that grows on a schedule set out in the policy, and it may receive dividends. Those are features of an insurance contract. A feature resembling something else does not change what the thing is.

Why people call it an investment anyway

Four reasons, and the first three are honest mistakes.

Because value accumulates. Something grows, and growth is the language of investing. But a contractual schedule is not a return, and it is not exposed to a market.

Because dividends are paid. The word is borrowed from corporate finance and does not mean the same thing. A participating policy dividend is a distribution from a pooled insurance account to policyholders who own no shares and hold no vote.

Because it is compared to investments. Any comparison implies the two are the same category. They are not, and the comparison is often the first error rather than the conclusion.

And because it sells better that way. This is the fourth reason and it is not a mistake. Framing insurance as an investment produces more sales, and it is precisely what a Canadian regulator ordered destroyed in training materials in December 2022. A practice that describes its product as an investment has misdescribed it, whatever it believes privately.

What the distinction protects

It sets what you should expect. Judged as a way to grow money against a low-cost portfolio over decades, a participating policy usually compares poorly. Judged as permanent coverage carrying a contractual value and an access mechanism, it is a different question with different inputs. Most disappointment in this product comes from applying the first test to something built for the second.

It determines which rules apply. Insurance and securities carry different disclosure obligations, different licensing and different consumer protections.

It keeps the advice inside the licence. An insurance advisor discussing insurance is operating within their authority. The same person recommending a policy as an alternative to a portfolio is not.

And it tells you what the product is for. The primary purpose is the death benefit. Everything else is a feature of a contract built for that.

What the strategy actually is

Practitioners describe an approach called The Infinite Banking Concept®, a term originated by Nelson Nash and a registered trademark of Infinite Banking Concepts, LLC. Neither this practice nor its author is affiliated with, sponsored by or endorsed by that company or the Nelson Nash Institute. Neither this practice nor any insurance policy is a bank, and a policy is not a deposit.

Nothing is invested in a policy. Premiums buy an insurance contract.

The strategy concerns how the contract's accessible value is used. Over a long period, the value in a participating contract can be reached through an advance and repaid, and the argument is about the discipline of doing that deliberately rather than about the contract earning a return.

The contract is the tool, not the point. Which is why an argument about whether the contract beats a portfolio is answering a question the strategy does not ask.

And the strategy is disputed on grounds that are partly correct, set out in objections and risks. A reader deciding about any of this is better served by starting there.

The four roles

Four jobs a household does with its own capital, whether or not it thinks about them.

The Saver. Sets money aside and forgoes its use in the meantime. The structural limit is that saved capital is either working or available, rarely both.

The Borrower. Obtains the use of capital now and pays for the privilege. The limit is that the cost is set by somebody else and the terms can change.

The Participant. Shares in the results of a pooled arrangement. The limit is that the capital producing those results is held by someone else, so the participation can be adjusted or withdrawn.

The Administrator. Decides where capital goes, in what order and on what terms. This is the only one of the four with no structural limit, and the only one that transfers to a family as a whole rather than to an individual.

The difficulty with the fourth role is behavioural, not structural, and saying so plainly is the point of naming them. It is available to you in every circumstance. Most households simply never exercise it deliberately.

What the contract actually provides

Stated precisely, because this is where the overstatement usually happens.

A death benefit, payable whenever death occurs, generally received free of income tax by a named beneficiary.

A guaranteed schedule of cash values, set out in the policy for each contract year. That schedule does not decrease, and it is a contractual obligation of the insurer, dependent on the insurer's solvency and not backed by any government. Assuris protects Canadian policyholders within published limits.

Amounts above that schedule depend on dividends, which are declared annually at the discretion of the insurer's board and are not guaranteed. The scale has moved historically and can move again.

The schedule is guaranteed. What sits above it is not. Those are different statements, and the earlier version of this page ran them together under a heading that promised growth was guaranteed, without qualifying which part.

Access to value during life, through an advance against the contract, with its own cost and tax consequences. It is set out on how a participating policy works, year by year.

What this practice does not do

It does not sell investments. The licence is for insurance.

It does not compare a policy to a portfolio as though they were the same category. Where a comparison is unavoidable, the honest form names what each product is for, and it appears on the honest case against this approach.

It does not describe a policy as a way to grow money. It is coverage with a contractual value.

And it is not neutral. Everything here is written by someone paid by commission from an insurer when a contract is issued, stated on the author page and at the foot of every page.

Where the framing goes wrong in practice

Four patterns, each of which reads as reasonable and each of which shifts the product into a category it does not belong in.

Quoting an internal rate of return. A figure can be calculated for a participating contract, and quoting it invites a comparison with a fund's return. The two numbers are not measuring the same thing: one includes the cost of a death benefit the other does not provide.

Describing the contractual value as an account balance. It is a value within a contract, not money held beside it. The word "account" imports expectations about liquidity and ownership that do not apply.

Presenting a projection without its guaranteed column. A projected value rests on a dividend scale nobody can promise. Shown alone it looks like a forecast, which is what an investment illustration looks like.

Comparing against a portfolio without saying what each is for. The comparison is not forbidden and it is frequently useful. What makes it misleading is omitting that one of the two pays a death benefit and the other does not.

None of these requires bad faith. Each is a shorthand that a practitioner uses because it is quicker, and each leaves a reader with a picture the product does not match.

What a reader should ask when they hear it described

Is this an insurance product or an investment product? The answer is insurance, and anyone who hesitates has told you something.

Which regulator governs it, and under what licence are you advising me?

What is guaranteed in writing, and what is not?

What does the guaranteed column show at years one, five and ten, against total premiums paid?

What happens if I need this money in three years?

Who should not buy this? An honest answer arrives quickly and is specific.

Those six questions separate a description from a pitch, and none of them requires any technical knowledge to ask.

Why this page exists at all

An unusual thing for a practice to publish, so the reason is worth stating.

The framing is the compliance issue in this industry, not the product. A participating whole life contract is an ordinary regulated product that suits some households and not others. What causes regulatory findings, and what causes disappointed clients, is describing it as something it is not.

And the correction has to be published, not merely believed. A practice that avoids the investment framing in private conversations while its website carries it has not corrected anything, because the website is what most people read.

The earlier version of this page made the right argument and undermined it with a heading promising that the growth itself was guaranteed. That combination is more common than either error alone: the correct thesis, stated alongside the language that contradicts it.

A note on the address of this page

This page sits at a URL containing the phrase "investing in life insurance", which is the framing the page exists to correct.

The address was kept deliberately. People search that phrase, in those words, because it is how the idea reaches them. A page that answers the question they actually typed, and corrects the premise inside it, is more use than one that declines to appear.

What was changed is everything a reader sees. The heading, the title, the description and the argument all state the position plainly.

A search term is not an endorsement of the assumption inside it. Meeting a reader where they are, and then being accurate, is different from adopting their error to be found.

The alternative was a page at a tidy address that nobody arrives at, while the question keeps being answered by whoever is willing to answer it. A correction that only appears where the mistake is not being made corrects nothing.

What "investment" means as a legal category

Worth setting out, because the distinction is not a matter of opinion about what a product feels like.

Securities legislation defines what a security is, and provincial securities acts list the instruments: shares, bonds, units of a fund, investment contracts, and others. Selling or advising on them requires registration with a securities regulator, now coordinated through the Canadian Securities Administrators, with the self-regulatory function held by CIRO.

Insurance legislation defines a policy of life insurance, and selling or advising on one requires a licence from a provincial insurance regulator. In Quebec that is the AMF, in Ontario FSRA, in British Columbia the Insurance Council of British Columbia.

These are separate statutes, separate regulators, separate licences and separate consumer protections. A person may hold one, both, or neither, and what they may lawfully say depends entirely on which.

Segregated funds sit at the boundary and are instructive. They are insurance contracts whose value tracks an underlying fund. They are sold under an insurance licence, carry a fund facts document, and are regulated as insurance despite behaving in some ways like a mutual fund. The category is determined by the legal form of the contract, not by what it resembles.

A participating whole life policy is not near that boundary. It is a policy of insurance, and nothing about it approaches the definition of a security.

The precedent that made this a compliance question

In December 2022, Ontario's regulator ordered a company to destroy training materials used with its agents.

What was found. Materials instructing agents to move the client away from thinking about insurance and toward thinking about saving and investing. Materials directing agents not to emphasise risk disclosures. Materials positioning insurance as superior to conventional investments without adequate disclosure of the differences.

Why it matters beyond that company. The finding was about how a product was described, not about the product. The contracts involved were ordinary regulated insurance policies. What attracted the order was the framing.

And the reach of the principle. Educational material, training content and marketing that functions as a sales funnel have all been assessed against advertising standards. A book, a seminar or a website that leads a reader toward a regulated product is promotional content, whatever it is called.

Which is why this page exists on a practice website rather than in an internal compliance file. The framing has to be corrected where the public reads it.

The comparisons that mislead, and the one that does not

Comparison is not forbidden. Most readers arrive holding one already, and refusing to engage with it helps nobody.

What makes a comparison misleading is asymmetry.

Comparing after-fee insurance values against before-fee investment returns, or the reverse. Either direction produces a false gap.

Comparing guaranteed insurance values against projected investment returns. A contractual floor and a hoped-for average are not comparable quantities.

Comparing over a chosen period. Any two products can be made to win by selecting the start and end dates.

Comparing without the death benefit. One of the two products pays out on death regardless of when it occurs. Omitting that from the comparison omits the main thing being bought.

Comparing against an investor's actual behaviour or against a spreadsheet. The honest version compares against what the household would realistically have done, not against an idealised alternative.

The comparison that survives scrutiny names what each product is for, holds the fee treatment symmetrical, shows the guaranteed column beside the projected one, and prices the death benefit rather than ignoring it. It usually shows that insurance is more expensive as a growth vehicle and provides something a portfolio does not. Both halves of that sentence are true and a comparison offering only one half is advocacy.

What happens when a household believes the wrong framing

Not an abstract concern. It produces a predictable sequence.

Year one. The values are far below premiums paid. A household expecting an investment reads this as a loss and frequently as evidence of a fraud.

Years three to seven. The gap narrows and remains negative. Every statement confirms the impression.

The first market rise the household misses. Comparison against what a portfolio did over the same period, on growth alone, is unflattering, because on that measure it should be.

Surrender. The contract ends in the early years, which is when it returns least. The loss is realised because the expectation was wrong, not because the product failed at what it was for.

And a taxable gain is sometimes crystallised on the way out, adding a bill to the disappointment.

Every step of that follows from the framing rather than from the contract. A household told it was buying permanent coverage with a slow-building contractual value, and shown the guaranteed column at year three before signing, does not experience any of it.

How to test a description you are given

Six checks a reader can apply without technical knowledge.

Does the description name what the product is? An insurance contract. If the word insurance does not appear early and plainly, that is the finding.

Is a rate of return quoted? If so, ask what it includes, and whether the comparison product provides a death benefit.

Is the guaranteed column shown? Not the projection. The floor.

Is the word "account" used for the contractual value? It imports expectations about liquidity and ownership that do not apply.

Is the death benefit described as incidental? It is the primary purpose, and a description treating it as a side effect has inverted the product.

Are you told who should not buy it? An accurate description of any product includes the people it does not suit, and the answer arrives quickly from someone describing rather than selling.

Why the distinction survives the strategy being disputed

A reader may finish this site unconvinced by the approach as a whole. The category point holds regardless.

The critics and the advocates agree on it, or should. The strongest criticisms of permanent insurance are that it is expensive as a growth vehicle, that early exit is punishing, and that it is sold to people it does not suit. None of those arguments requires the product to be an investment, and the first is only coherent if it is not.

Where the two sides genuinely differ is whether the coverage and the access mechanism are worth the cost for a particular household. That is a real disagreement and it is examined at what the critics get right, and what they leave out.

What both sides should refuse is the framing that makes the disagreement unresolvable, because two people arguing about whether an insurance contract is a good investment are arguing about a question with no correct answer.

What this page will not do

It will not tell you the product suits you.

Whether permanent coverage with an access mechanism fits depends on whether the need is genuinely permanent, whether the cash flow is durable across decades, and what registered contribution room you have not used. Those are facts about you.

And if what you actually want is investment growth, this is the wrong product, and a page published by an insurance practice should be willing to say so directly rather than leave it to be inferred.

The product itself is on whole life insurance in Canada, and the approach Nelson Nash named The Infinite Banking Concept® is set out across these pages, including the arguments against it.

The test that settles it in one question

Which regulator supervises this product, and under what licence are you advising me?

Insurance is supervised provincially, by the AMF in Quebec, FSRA in Ontario and the insurance councils elsewhere, and it is sold under an insurance licence.

Securities are supervised by the provincial securities commissions with CIRO as the self-regulatory body, and require separate registration.

A participating whole life contract is the first, without ambiguity.

Anyone who hesitates on that question, or answers both, has told you something that no amount of further description will correct.

Why the framing matters more than the argument

Two people arguing about whether an insurance contract is a good investment are arguing about a question with no correct answer.

The critics and the practitioners can both be right, because they are describing different things. Fixing the category is what makes the disagreement resolvable, and it is why this page exists before any of the others.

The one distinction

An insurance contract that accumulates a value.

Not an investment that carries a death benefit.

Same document, different expectations, and only one of them survives thirty years without a surprise.

Hold that distinction and the rest of this site is checkable. Lose it and every page after this one will be read against the wrong measure.

Every other page on this site assumes you are holding it. The mechanics, the costs, the objections and the strategy all read differently depending on which category you have placed the contract in, which is why this page comes first rather than last.

Which is why it is worth being certain before going further. A reader holding the wrong category will misread every page after this one, and will blame the product for failing a test it was never built to pass.

One sentence to take away

A participating whole life contract is an insurance policy that happens to accumulate a contractual value. It is not an investment that happens to carry a death benefit.

Those two descriptions point at the same document and produce entirely different expectations. The first is accurate, and a reader holding it will not be surprised by anything the contract does over the next thirty years.

The second is how the product is most often sold, and it is where nearly every complaint about it begins.

Nothing else on this site depends on a reader accepting the strategy. It does depend on their holding that one distinction, because every other page assumes it.